Clinical Trial Update: Non-Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating non-invasive PET imaging with [18F]HX4 in cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• [18F]HX4

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Cancer | Phase 1 | Status: COMPLETED